Health Movement
Health Made Simple
Apps
Steps
Fitness, coming later
Facts over Fear Free Tools Programs Apparel Free Roadmap
The claim

“Rapamycin slows aging in healthy people.”

Mostly false
Evidence confidence Limited
The short answer

Rapamycin has not been shown to slow aging in healthy people, and the one year-long trial in healthy adults missed its main goal.

What this means for you

Taking rapamycin for longevity today means accepting real drug risks for a benefit that has not been shown in people. The safest way to try it is in a registered clinical trial.

Your next step

If you are interested, search ClinicalTrials.gov for a rapamycin aging trial you could join instead of buying it online.

Who should be careful?

Safety note: Rapamycin (sirolimus) is a prescription drug used to suppress the immune system after kidney transplants. Its label lists higher risk of infections, mouth sores, higher cholesterol and blood sugar, slow wound healing and drug interactions, and advises avoiding live vaccines; long-term safety of low-dose intermittent use in healthy people is not known.

Talk to a healthcare professional if: you are thinking about taking rapamycin. Use it only through a prescriber who can review interactions, infections, vaccines, planned surgery and lab monitoring, and never from an unverified seller.

The evidence
Why this confidence?

The one year-long placebo-controlled trial in healthy adults missed its main outcome and found only a few secondary benefits. It was small, used a compounded drug with low blood levels and was run by a company that sells rapamycin, so it cannot settle the question either way.

The facts

Rapamycin has not been shown to slow aging in healthy people, and the one year-long trial in healthy adults missed its main goal. In the PEARL trial, 114 adults who completed 48 weeks of low-dose weekly rapamycin had no change in visceral (belly) fat, the main outcome; women on 10 mg gained some lean mass and reported less pain, and some users reported better well-being. Side effects were similar to placebo, and the trial did not measure aging itself or lifespan.

The bigger picture

Rapamycin extends lifespan in mice, and blocking the same pathway extends life in yeast, worms and flies, which makes it a serious research candidate. A 2024 review of 19 human studies found that rapamycin and related drugs improved some immune, heart and skin measures linked to aging, with no clear effect on hormone, muscle or brain measures; in people who already had aging-related diseases, infections and cholesterol went up. Animal longevity and a handful of human healthspan measures are not the same as slower human aging.

Last reviewed 2026-10-21 We update these cards as new research comes out. When the evidence changes, our verdicts change too.
Suggest a correction →